Skip to main content

Table 1 Clinical characteristics of patients with ITP

From: Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia

Patient Gender Age Platelets (×109/L) Bleeding symptoms Major therapy Platelets (×109/L)
Before treatment After treatment
1 F 54 23 EC GC 118
2 F 37 6 EC, PT GC 154
3 F 23 15 EC, EP GC 98
4 F 58 18 EP, GUH GC 222
5 F 48 3 EC, GUH GC 245
6 M 67 12 PT GC 97
7 F 40 10 PT GC 56
8 M 59 4 EC GC 234
9 F 60 27 EC, GUH GC 67
10 M 70 10 EC, PT GC 21
11 M 49 9 PT GC 180
12 M 12 34 EC GC 78
13 F 13 21 EC GC 203
14 F 26 10 EC, GIH GC 82
15 F 28 19 EC GC 168
16 M 65 20 EC, GIH GC 166
17 M 42 11 PT GC 267
18 F 17 9 EC GC 80
19 F 56 2 PT GC 9
20 M 61 27 PT GC 174
21 F 63 10 EC, GH GC 199
22 F 50 14 EC, PT GC 143
23 M 31 11 EC GC 20
24 F 26 25 PT GC 156
25 F 71 21 PT GC 151
26 F 51 28 EC, GUH GC 32
27 F 28 8 PE, PT, ET GC 103
28 F 24 9 EC, EP GC 197
29 F 29 16 PT GC 173
30 F 34 22 PT GC 129
31 F 41 7 PE, PT GC 301
32 F 20 5 EC, GUH GC 24
33 M 25 23 PT GC 71
34 M 37 3 PT GC 96
35 F 19 2 EC, PT GC 136
36 M 33 7 PT GC 84
37 F 46 16 PT GC 183
38 F 42 10 PT GC 158
Median   40.5 10    148.5
Range   12–71 2–34    9–301
  1. EC ecchymoses; GC glucocorticoid; PT petechiae; EP epistaxis; GUH genitourinary hemorrhage; GIH gastrointestinal hemorrhage; GH gingival hemorrhage